Filtered By:
Vaccination: Covid Vaccine
This page shows you your search results in order of relevance. This is page number 12.
Order by Relevance | Date
Total 848 results found since Jan 2013.
COVID-19 Vaccine Administration in Patients with Reported Reactions to Polyethylene Glycol- and Polysorbate-Containing Therapeutics
Background: Polyethylene glycol (PEG) and polysorbate reactions were initially implicated as a likely risk factor for reacting to COVID-19 vaccines and remain a source of vaccine hesitancy despite increasing evidence that they do not pose an increased risk for COVID-19 vaccine reactions.Objective: To investigate COVID-19 vaccine safety outcomes in patients with reported reactions to PEG and polysorbate containing medications/vaccines.Methods: COVID-19 vaccine safety was reviewed in patients identified with PEG/polysorbate reactions documented in their electronic medical records at a tertiary academic medical center (cohort...
Source: Annals of Allergy, Asthma and Immunology - March 11, 2022 Category: Allergy & Immunology Authors: Iris M. Otani, Lulu R. Tsao, Monica Tang Source Type: research
AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy
Immediate hypersensitivity reactions to COVID-19 vaccines have been postulated to be linked to their excipients, such as polyethylene glycol (PEG) in Pfizer Comirnaty, or polysorbate 80 and ethylenediaminetetr...
Source: Allergy, Asthma and Clinical Immunology - March 10, 2022 Category: Allergy & Immunology Authors: Syed B. Ali, Griffith Perkins, Dongjae Ryoo, Maverick Lee, Matthew Tunbridge, Chino Yuson, William Smith, Pravin Hissaria and Thanh-Thao Le Tags: Case report Source Type: research
Graded COVID-19 Vaccine Administration: A Safe Alternative to Vaccine Avoidance
Ann Allergy Asthma Immunol. 2022 Mar 4:S1081-1206(22)00173-9. doi: 10.1016/j.anai.2022.02.024. Online ahead of print.NO ABSTRACTPMID:35257875 | PMC:PMC8894737 | DOI:10.1016/j.anai.2022.02.024
Source: Annals of Allergy, Asthma and Immunology - March 8, 2022 Category: Allergy & Immunology Authors: Mitchell M Pitlick Alexei Gonzalez-Estrada Miguel A Park Source Type: research
Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research
Graded coronavirus disease 2019 vaccine administration
As the coronavirus disease 2019 (COVID-19) pandemic has unfolded and evolved over the past 2 years, so too have recommendations surrounding COVID-19 vaccination. Third and fourth vaccine doses are being approved for a wide variety of age groups, signaling the ongoing need for safe vaccine administration in hopes of controlling the pandemic. Concerns surrounding COVID-19 vaccine allergy have persisted throughout the vaccination period. A strategy for skin testing to evaluate these concerns was previously outlined, but subsequent studies reported limited utility in its use.
Source: Annals of Allergy, Asthma and Immunology - March 3, 2022 Category: Allergy & Immunology Authors: Mitchell M. Pitlick, Alexei Gonzalez-Estrada, Miguel A. Park Tags: Letters Source Type: research
Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research
